Net Income (Quarterly) Chart

View Net Income (Quarterly) for ATAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -32.55M
March 31, 2026 -29.80M
December 31, 2025 -544.84M
September 30, 2025 -61.10M
June 30, 2025 -27.75M
March 31, 2025 -26.46M
September 30, 2024 -26.31M
June 30, 2024 -57.37M
March 31, 2024 -27.38M
December 31, 2023 -19.14M
September 30, 2023 43.37M
June 30, 2023 -33.77M
March 31, 2023 -34.35M
Date Value
December 31, 2022 -46.65M
September 30, 2022 -35.70M
June 30, 2022 -37.51M
March 31, 2022 -37.56M
December 31, 2021 -93.27M
September 30, 2021 -31.64M
June 30, 2021 -53.37M
March 31, 2021 4.044M
December 31, 2020
September 30, 2020 -83.19M
June 30, 2020 -16.96M
March 31, 2020 15.88M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 7.095B
GH Research Plc -15.15M
Johnson & Johnson 5.534B
Merck & Co., Inc. -1.337B
Zoetis, Inc. 691.00M